Gara Jalqabaatti › Dhibee Gaddii Guddaa › California › Orange
Qorannoo klinikaalii Dhibee Gaddii Guddaa Orange, CA keessatti
Qorannoo 13 Dhibee Gaddii Guddaa f Orange fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Namoota walitti qabaa jiraSadarkaa 2
- PNS Clinical Research LLC dba ATP Clinical Research, Orange
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 3
- ATP Clinical Research, Orange
- NRC Research Institute, Orange
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Namoota walitti qabaa jiraSadarkaa 3
- ATP Clinical Research Orange County, Orange
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 3
- ATP Clinical Research, Orange
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 3
- NRC Research Institute, Orange
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Namoota walitti qabaa jiraSadarkaa 2
- Nrc Research Institute, Orange
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 3
- Vanda Investigational Site, Orange
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Namoota walitti qabaa jiraSadarkaa 4
- Neurocrine Clinical Site, Orange
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Namoota walitti qabaa jiraSadarkaa 3
- Atp Clinical Research, Orange
- Nrc Research Institute, Orange
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Namoota walitti qabaa jiraSadarkaa 3
- Neurocrine Clinical Site, Orange
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Namoota walitti qabaa jiraSadarkaa 3
- Neurocrine Clinical Site, Orange
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Namoota walitti qabaa jiraSadarkaa 2
- Autobahn Site #152, Orange
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Namoota walitti qabaa jiraSadarkaa 3
- Neurocrine Clinical Site, Orange
Qorannoo Dhibee Gaddii Guddaa magaalota biroo keessatti
- New York City, NYQorannoo 36
- Boston, MAQorannoo 31
- Atlanta, GAQorannoo 25
- Philadelphia, PAQorannoo 23
- Orlando, FLQorannoo 19
- Miami, FLQorannoo 18
- Chicago, ILQorannoo 17
- Tampa, FLQorannoo 17
- San Diego, CAQorannoo 16
- Houston, TXQorannoo 16
- Little Rock, ARQorannoo 14
- Austin, TXQorannoo 13
Qorannoo biroo Orange keessatti
- Kansara Qara'a Non-Small CellQorannoo 25
- Kansara MetastatikiiQorannoo 20
- Kansarii ColorectalQorannoo 16
- Kansarii OvariiQorannoo 16
- Kansarii PancreasQorannoo 15
- MelanomaQorannoo 14
- Dhibee Harkaa (Hepatocellular Carcinoma)Qorannoo 14
- Saree OljooQorannoo 14
- Dhibee QaraQorannoo 14
- Kansarii ProstateQorannoo 14
- Kanisa HarkaaQorannoo 13
- Saree (Gosoota Hunda)Qorannoo 13
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.